Marathon Petroleum Brings in Finance Veteran Maria Khoury as New CFO

MidnightSeller · 2026-01-04T14:26:27+00:00

Marathon Petroleum Corporation has appointed Maria Khoury as Chief Financial Officer, effective January 19, 2026. With extensive experience in finance across biotech and energy sectors, she aims to strengthen the company's financial leadership.

MidnightSeller

2026-01-04 14:26:27

Abstract generation in progress

Marathon Petroleum Corporation has secured Maria Khoury to lead its financial operations, filling the Chief Financial Officer and Executive Vice President role starting January 19, 2026. She takes over the position previously held by John Quaid.

Khoury brings substantial cross-industry experience spanning healthcare, biotech, and energy sectors. Most recently, she held the title of Vice President and Group CFO for Biotechnology at Danaher Corporation since 2021, where she oversaw financial operations for two major divisions: Cytiva and Pall Life Sciences. Her track record in complex financial management extends across multiple Fortune 500 environments.

Prior to her tenure at Danaher, Khoury spent three years as Vice President of Finance and IT at GE Healthcare Life Sciences from 2017 through 2020. This role followed seven years in increasingly senior finance positions at GE Oil & Gas, where she managed financial strategies across U.S. and Italian operations and served as Chief Financial Officer for the Drilling and Surface division.

Her appointment underscores Marathon Petroleum’s emphasis on bringing financial leadership with deep industry expertise to navigate the energy sector’s complexities. Khoury’s background across biotech, healthcare technology, and oil and gas provides a diverse perspective for managing the company’s fiscal direction.

Disclaimer: The perspectives shared in this analysis represent the author’s views and do not constitute official statements from Nasdaq, Inc.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.